Profil Penderita Kanker Serviks Berdasarkan Stadium di RSUP Prof. Dr. I.G.N.G Ngoerah Denpasar Bali Periode 1 Januari 2022 – 1 Januari 2023

  • I Nyoman Bayu Mahendra Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital
  • I Nyoman Gede Budiana Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital
  • I Gde Sastra Winata Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital
  • Kade Yudi Saspriyana Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital
Keywords: Kanker serviks, paritas, stadium, usia

Abstract

Kanker serviks merupakan jenis kanker paling umum yang terjadi pada wanita di Indonesia, dengan proporsi sekitar 16% dari seluruh jenis kanker. Tujuan penelitian ini adalah untuk mengidentifikasi profil dan pola distribusi kanker serviks pada wanita di RSUP Prof. I.G.N.G Ngoerah Denpasar selama periode 1 Januari 2022 – 1 Januari 2023. Penelitian ini menggunakan rancangan deskriptif retrospektif dengan menggunakan semua data rekam medis pasien kanker serviks di RSUP Prof I.G.N.G Ngoerah pada periode 1 Januari 2022 – 1 Januari 2023. Untuk memilih sampel, digunakan metode purposive sampling dengan kriteria inklusi yang sesuai, dan data kemudian disajikan dalam bentuk tabel dan grafik. Total kasus baru kanker serviks selama periode 1 Januari 2022 – 1 Januari 2023 adalah 302. Mayoritas penderita kanker serviks memiliki rentang usia 50-60 tahun, yakni sebanyak 103 (34,1%). Bedasarkan data tersebut, sebagian besar subjek penelitian adalah tidak pernah melahirkan, yakni sebanyak 135 (44,7%). Untuk stadium yang paling dominan mengenai pasien wanita kanker serviks adalah stadium IIIB sejumlah 158 orang (52.3%). Sebagian besar pasien kanker serviks di RSUP Prof Ngoerah Desnpasar memiliki rentang usia 50-60 tahun dengan stadium IIIB.

Downloads

Download data is not yet available.

References

International Agency for Research on Cancer. (2020). GLOBOCAN Indonesia.

Dunyo, P., Effah, K., & Udofia, E. A. (2018). Factors associated with late presentation of cervical cancer cases at a district hospital: A retrospective study. BMC Public Health, 18(1), 1156. https://doi.org/10.1186/s12889-018-6065-6

Federico, C., Alleyn, J., Dola, C., Tafti, S., Galandak, J., Jacob, C., Bhuiyan, A., & Cheng, J. (Pui). (2010). Relationship Among Age, Race, Medical Funding, and Cervical Cancer Survival. Journal of the National Medical Association, 102(3), 199–205. https://doi.org/10.1016/S0027-9684(15)30526-5

Ferrante JM, Gonzalez EC, Roetzheim RG, Pal N, Woodard L. (2000). Clinical and de-mographic predictors of late-stage cervical cancer. Arch Fam Med;9(5):439-445. doi:10.1001/archfami.9.5.439

Pratiwi, E.H., Malik, N. (2022). Analisis Pengaruh Pertumbuhan Ekonomi, Tingkat Pendidikan dan Kesehatan Terhadap Jumlah Penduduk Miskin di Bali Tahun 2011-2020. Jurnal Ilmu Ekonomi Indonesia.

Johnson CA, James D, Marzan A, Armaos M. (2019). Cervical Cancer: An Overview of Pathophysiology and Management. Semin Oncol Nurs;35(2):166-174. doi:10.1016/j.soncn.2019.02.003

Kashyap, N., Krishnan, N., Kaur, S., & Ghai, S. (2019). Risk Factors of Cervical Can-cer: A Case-Control Study. Asia-Pacific Journal of Oncology Nursing, 6(3), 308–314. https://doi.org/10.4103/apjon.apjon_73_18

Kumar, V., Abbas, A. K., Aster, J. C., & Perkins, J. A. (Eds.). (2018). Robbins basic pathology (Tenth edition). Elsevier.

Liao, S.-F., Lee, W.-C., Chen, H.-C., Chuang, L.-C., Pan, M.-H., & Chen, C.-J. (2012). Baseline human papillomavirus infection, high vaginal parity, and their interaction on cervical cancer risks after a follow-up of more than 10 years. Cancer Causes & Control, 23(5), 703–708. https://doi.org/10.1007/s10552-012-9939-4

Okunade, K. S. (2020). Human papillomavirus and cervical cancer. Journal of Obstetrics and Gynaecology, 40(5), 602–608. https://doi.org/10.1080/01443615.2019.1634030
Kemenkes. (2017). Pedoman Nasional Pelayanan Kedokteran Kanker Serviks.

Phaiphichit, J., Paboriboune, P., Kunnavong, S., & Chanthavilay, P. (2022). Factors as-sociated with cervical cancer screening among women aged 25–60 years in Lao People’s Democratic Republic. PLOS ONE, 17(4), e0266592. https://doi.org/10.1371/journal.pone.0266592

Prabasari, C. I. W., & Budiana, I. N. G. (2017). Profil Penderita Kanker Serviks Di Ru-mah Sakit Umum Pusat Sanglah Denpasar, Bali Periode Juli 2012 – Juni 2013. 6(8).

Salvo, G., Odetto, D., Saez Perrotta, M. C., Noll, F., Perrotta, M., Pareja, R., Wernicke, A., & Ramirez, P. T. (2020). Measurement of tumor size in early cervical cancer: An ever-evolving paradigm. International Journal of Gynecologic Cancer, 30(8), 1215–1223. https://doi.org/10.1136/ijgc-2020-001436

Scarth, J. A., Patterson, M. R., Morgan, E. L., & Macdonald, A. (2021). The human papillomavirus oncoproteins: A review of the host pathways targeted on the road to transformation. Journal of General Virology, 102(3). https://doi.org/10.1099/jgv.0.001540

Tekalegn, Y., Sahiledengle, B., Woldeyohannes, D., Atlaw, D., Degno, S., Desta, F., Bekele, K., Aseffa, T., Gezahegn, H., & Kene, C. (2022). High parity is associated with increased risk of cervical cancer: Systematic review and meta-analysis of case–control studies.

Tekalign, T., & Teshome, M. (2022). Prevalence and determinants of late-stage presenta-tion among cervical cancer patients, a systematic review and meta-analysis. PLOS ONE, 17(4), e0267571. https://doi.org/10.1371/journal.pone.0267571

Zhang, S., Xu, H., Zhang, L., Qiao, Y., Department of Cancer Epidemiology, Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Engineer-ing Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou 450008, China, & Department of Ep-idemiology, National Cancer Center, Chinese Academy of Medical Sciences, School of Population Medicine and Public Health, Peking Union Medical College, Beijing 100021, China. (2020). Cervical cancer: Epidemiology, risk factors and screening. Chinese Journal of Cancer Research, 32(6), 720–728. https://doi.org/10.21147/j.issn.1000-9604.2020.06.05
Published
2022-11-20